Ticker
IMNN
Analysis
Imunon, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to IMNN.
Imunon, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to IMNN.
IMNN
Stock
$7.6M
Health Technology
Biotechnology
USD
Imunon, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
LAWRENCEVILLE, N.J., June 22, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today an...
IMUNON Announces Up to $10 Million Cash Financing
IMNN-001 is the First and Only frontline treatment candidate to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with ovar...
LAWRENCEVILLE, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, announ...
IMNN-001 is the first frontline immunotherapy to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with
Review valuation context for Imunon, Inc..
Review future growth context for Imunon, Inc..
Review past performance context for Imunon, Inc..
Review financial health context for Imunon, Inc..
Review dividend context for Imunon, Inc..
Review management context for Imunon, Inc..
Review ownership context for Imunon, Inc..
Review other information context for Imunon, Inc..
Review community context for Imunon, Inc..